Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01869829 · ClinicalTrials.gov registry record
PEACE: Pediatric Antifungal Comparative Effectiveness
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 750
- Enrollment target
NCT01869829 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 750 participants.
The verdict
NCT01869829 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
The overarching objective is to develop new evidence-based treatment guidelines for invasive fungal diseases in children. To accomplish that, this protocol will focus on two specific aims: 1) Compare the effectiveness of echinocandin versus amphotericin B or triazole antifungal therapy for pediatric invasive candidiasis and for the subset of patients with invasive candidemia; 2) Characterize the incidence rate of inpatient pediatric invasive candidiasis per hospital admissions.
Interventions
- DRUG Observational antifungal therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2015-01 |
| Est. Completion | 2018-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01869829
The ClinicalTrials.gov registry entry for NCT01869829 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 750 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Observational antifungal therapy is the first listed.
NCT01869829 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01869829 about?
NCT01869829 is a clinical study titled "PEACE: Pediatric Antifungal Comparative Effectiveness". The overarching objective is to develop new evidence-based treatment guidelines for invasive fungal diseases in children. To accomplish that, this protocol will focus on two specific aims: 1) Compare the effectiveness of echinocandin versus amphotericin B or triazole antifungal therapy for pediatric...
What is the current status of trial NCT01869829?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2015-01. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01869829?
The interventions under investigation include: Observational antifungal therapy (DRUG).
Who is sponsoring clinical trial NCT01869829?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.